Feasibility of screening for T1D and celiac disease in a pediatric clinic setting

Pediatric Diabetes

Volumn 17, Issue 6, 2016, Pages 441-448

  Gesualdo, Patricia D ^a   Bautista, Kimberly A ^a   Waugh, Kathleen C ^a   Yu, Liping ^a   Norris, Jill M ^b   Rewers, Marian J ^a   Baxter, Judith ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b Food Science and Human Nutrition   (United States)

Author keywords

celiac disease; childhood diabetes; feasibility; islet autoantibody; pediatric screening

Indexed keywords

AUTOANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; EARLY DIAGNOSIS; FEASIBILITY STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PARENTAL CONSENT; PARENTAL SATISFACTION; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; REFUSAL TO PARTICIPATE; SATISFACTION; SCREENING TEST;

EID: 84982973191     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12301     Document Type: Article

References (48)

1. Dabelea D, Mayer-Davis EJ, Saydah S et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014: 311: 1778–1786.
2. Rewers A, Klingensmith G, Davis C et al. Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics 2008: 121: e1258–e1266.
3. Rewers A, Dong A, Slover RH, Klingensmith GJ, Rewers M. Prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in youth in Colorado, 1998-2012. JAMA 2015: 313: 1570–1572.
4. Fredheim S, Johannesen J, Johansen A et al. Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels. Diabetologia 2013: 56: 995–1003.
5. Ghetti S, Lee JK, Sims CE, Demaster DM, Glaser NS. Diabetic ketoacidosis and memory dysfunction in children with type 1 diabetes. J Pediatr 2010: 156: 109–114.
6. Bonifacio E, Yu L, Williams AK et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. J Clin Endocrinol Metab 2010: 95: 3360–3367.
7. Barker JM, Goehrig S, Barriga K et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 2004: 27: 1399–1404.
8. Elding Larsson H, Vehik K, Bell R et al. Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care 2011: 34: 2347–2352.
9. Triolo TM, Chase HP, Barker JM, Group DPTS. Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset. Diabetes Care 2009: 32: 769–773.
10. Vanelli M, Chiari G, Ghizzoni L, Costi G, Giacalone T, Chiarelli F. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care 1999: 22: 7–9.
11. Fritsch M, Schober E, Rami-Merhar B et al. Diabetic ketoacidosis at diagnosis in Austrian children: a population-based analysis, 1989-2011. J Pediatr 2013: 163: 1484–1488.e1481.
12. Catassi C, Gatti S, Fasano A. The new epidemiology of celiac disease. J Pediatr Gastroenterol Nutr 2014: 59 (Suppl. 1): S7–S9.
13. Kordonouri O, Klingensmith G, Knip M et al. ISPAD Clinical Practice Consensus Guidelines. Other complications and diabetes-associated conditions in children and adolescents. Pediatr Diabetes 2014: 2014 (15 Suppl. 20): 270–278.
14. Adlercreutz EH, Svensson J, Hansen D et al. Prevalence of celiac disease autoimmunity in children with type 1 diabetes: regional variations across the Oresund strait between Denmark and southernmost Sweden. Pediatr Diabetes [Epub ahead of print 2014 Aug 18].
15. Husby S, Koletzko S, Korponay-Szabo IR et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012: 54: 136–160.
16. Warncke K, Liptay S, Frohlich-Reiterer E et al. Vascular risk factors in children, adolescents, and young adults with type 1 diabetes complicated by celiac disease: results from the DPV initiative. Pediatr Diabetes [Epub ahead of print 2015 Feb 12].
17. Krischer JP, Lynch KF, Schatz DA et al. The six-year incidence of diabetes associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia 2015: 58: 980–987.
18. Dabelea D, Bell RA, D'Agostino RB Jr et al. Incidence of diabetes in youth in the United States. JAMA 2007: 297: 2716–2724.
19. Yu L, Robles DT, Abiru N et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 2000: 97: 1701–1706.
20. Wenzlau JM, Juhl K, Yu L et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007: 104: 17040–17045.
21. Bao F, Yu L, Babu S et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 1999: 13: 143–148.
22. Li M, Yu L, Tiberti C et al. A report on the International Transglutaminase Autoantibody Workshop for celiac disease. Am J Gastroenterol 2009: 104: 154–163.
23. Yu L, Miao D, Scrimgeour L, Johnson K, Rewers M, Eisenbarth GS. Distinguishing persistent insulin autoantibodies with differential risk: nonradioactive bivalent proinsulin/insulin autoantibody assay. Diabetes 2012: 61: 179–186.
24. Miao D, Guyer KM, Dong F et al. GAD65 autoantibodies detected by electrochemiluminescence assay identify high risk for type 1 diabetes. Diabetes 2013: 62: 4174–4178.
25. Elding Larsson H, Vehik K, Gesualdo P et al. Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatr Diabetes 2014: 15: 118–126.
26. Rewers M, Norris JM, Eisenbarth GS et al. Beta-cell autoantibodies in infants and toddlers without IDDM relatives: diabetes autoimmunity study in the young (DAISY). J Autoimmun 1996: 9: 405–410.
27. Liu E, Lee HS, Aronsson CA et al. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med 2014: 371: 42–49.
28. Childhood Diabetes Research Committee Ministry of Health and Welfare-Japan, Polish Diabetes Research Group-Poznan, The Netherlands Institute for Preventitive Health Care-Leiden, Diabetes Reseach Center of Pittsburg, Pennsylvania. How frequently do children die at the onset of insulin-dependent diabetes mellitus? Analyses of registry data from Japan, Poland, the Netherlands and Allegheny County, Pennsylvania. Diab Nutr Metab 1990: 3: 57–62.
29. Colorado Health Institute. Analysis of the Colorado Health Access 2013 Survey, 2014.
30. Jollye S. An exploratory study to determine how parents decide whether to enroll their infants into neonatal clinical trials. J Neonatal Nurs 2009: 15: 18–24.
31. Mazzocco M, Harum KH, Myers G, Reiss A. Children's participation in genetic prevalence research: influences on enrollment and reports of parent satisfaction. J Appl Soc Psychol 1999: 29: 2308–2327.
32. Chantler TE, Lees A, Moxon ER, Mant D, Pollard AJ, Fiztpatrick R. The role familiarity with science and medicine plays in parents' decision making about enrolling a child in vaccine research. Qual Health Res 2007: 17: 311–322.
33. Langley JM, Halperin SA, Mills EL, Eastwood B. Parental willingness to enter a child in a controlled vaccine trial. Clin Invest Med 1998: 21: 12–16.
34. Bernhardt BA, Tambor ES, Fraser G, Wissow LS, Geller G. Parents' and children's attitudes toward the enrollment of minors in genetic susceptibility research: implications for informed consent. Am J Med Genet A 2003: 116A: 315–323.
35. Tait AR, Voepel-Lewis T, Siewert M, Malviya S. Factors that influence parents' decisions to consent to their child's participation in clinical anesthesia research. Anesth Analg 1998: 86: 50–53.
36. Baxter J, Vehik K, Johnson SB, Lernmark B, Roth R, Simell T. Differences in recruitment and early retention among ethnic minority participants in a large pediatric cohort: the TEDDY Study. Contemp Clin Trials 2012: 33: 633–640.
37. Lernmark B, Johnson SB, Vehik K et al. Enrollment experiences in a pediatric longitudinal observational study: The Environmental Determinants of Diabetes in the Young (TEDDY) study. Contemp Clin Trials 2011: 32: 517–523.
38. TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann N Y Acad Sci 2008: 1150: 1–13.
39. Rewers M, Bugawan TL, Norris JM et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 1996: 39: 807–812.
40. Maclaren NK, Lan MS, Schatz D, Malone J, Notkins AL, Krischer J. Multiple autoantibodies as predictors of type 1 diabetes in a general population. Diabetologia 2003: 46: 873–874.
41. Reilly NR, Green PH. Epidemiology and clinical presentations of celiac disease. Semin Immunopathol 2012: 34: 473–478.
42. Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the United States. Am J Gastroenterol 2012: 107: 1538–1544; quiz 1537, 1545.
43. Carroccio A, Di Prima L, Falci C et al. Predictive value of serological tests in the diagnosis of celiac disease. Ann Ital Med Int 2002: 17: 102–107.
44. Reeves GE, Squance ML, Duggan AE et al. Diagnostic accuracy of coeliac serological tests: a prospective study. Eur J Gastroenterol Hepatol 2006: 18: 493–501.
45. Singh P, Kurray L, Agnihotri A et al. Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease. J Clin Gastroenterol 2014: 49: 212–217.
46. Fasano A, Berti I, Gerarduzzi T et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003: 163: 286–292.
47. Garcia-Manzanares A, Tenias JM, Lucendo AJ. Bone mineral density directly correlates with duodenal Marsh stage in newly diagnosed adult celiac patients. Scand J Gastroenterol 2012: 47: 927–936.
48. Theethira TG, Dennis M, Leffler DA. Nutritional consequences of celiac disease and the gluten-free diet. Expert Rev Gastroenterol Hepatol 2014: 8: 123–129.